 |
 |

Is Pharmaceutical Sponsorship of a Dermatologic Conference Proper?
H. A. Martino Neumann, MD, PhD
From the Department of Dermatology, Academisch Ziekenhuis Maastricht, Maastricht, the Netherlands.
Arch Dermatol. 1999;135:645-646.
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
When Alfred Hardy and his staff, which consisted of only a single person, organized the first International (World) Congress of Dermatology and Syphilology at the Hôpital Saint-Louis in August 1889 in Paris, France, it was a meeting of 220 scientists who sought to learn from each other by exchanging experiences and ideas. In those days, dermatology was medicine that was based mainly on experience alone, although, even then, great dermatologists tried to practice medicine predicated on evidence as well. As one example of that conflict in mentality, Wickham called attention to the fact that Paget disease of the nipple could be recognized morphologically as distinct from eczema. Despite his knowing that the process on the nipple was related to cancer, he nonetheless asserted that it was a parasitic disease, "since the psorosperms could even be seen in the scales being shed."1
More than 100 . . . [Full Text of this Article]
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
The Propriety of Sponsorship of Dermatologic Conferences
Ortonne et al.
Arch Dermatol 2000;136:308-310.
FULL TEXT
Shadow of a Doubt
Mascaro
Arch Dermatol 2000;136:310-311.
FULL TEXT
|